Fundz
New|Fundz now works inside Claude2 min

See what’s changing first. Know which accounts matter next.

Fundz catches funding rounds before they’re announced, and acquisitions, new executives, hiring shifts and contract wins as they happen. It weighs them against your ideal customer profile and delivers a ranked shortlist every morning, with the evidence, the reason to reach out and the decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Anupam Rasayan to acquire 74.20% in Bliss GVS

PRIVATESep 27, 2026

Acquiring Company

Anupam Rasayan India

Acquired Company

Bliss GVS Pharma Limited

SachinMumbaiManufacturingBiotechnologyAgriculture and FarmingManufacturingBiotechnologyPharmaceutical

Description

Anupam Rasayan India Limited has agreed to acquire a 43.30% stake in Bliss GVS Pharma Limited for ₹1,369.51 crore. This acquisition involves purchasing equity shares from the promoter group members and public shareholders, with a total transaction value of approximately ₹2,198.54 crore for up to 74.20% equity. The acquisition aims to enhance Anupam Rasayan's presence in the pharmaceutical sector.

Company Information

Company

Anupam Rasayan India

Location

Sachin, Gujarat, India

About

Anupam Rasayan India Limited® is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India. With our customers at the heart of everything we do, our focus is to manufacture products with sustainability using our continuous process technology through flow chemistry and photo chemistry, greater R&D and engineering capabilities to deliver values for our customers for their complex and multi-step synthesis projects. Stay on top of industry trends. Keep up-to-date with our latest news and join the conversation on social media.

Fundz sees it the moment Anupam Rasayan India makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Gopal
Senior decision-maker at this company
••••••••@••••••••

See Gopal's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Anupam Rasayan India's next move

Learn about Strategic plan

Frequently asked

Who acquired Bliss GVS Pharma Limited?

Bliss GVS Pharma Limited was acquired by Anupam Rasayan India, based in Sachin. The deal was reported on September 27, 2026. Anupam Rasayan India Limited® is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India. Anupam Rasayan India is privately held and operates in Manufacturing.

When did Anupam Rasayan India acquire Bliss GVS Pharma Limited?

Anupam Rasayan India's acquisition of Bliss GVS Pharma Limited was reported on September 27, 2026. Anupam Rasayan India Limited has agreed to acquire a 43.30% stake in Bliss GVS Pharma Limited for ₹1,369.51 crore. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Bliss GVS Pharma Limited do?

Bliss GVS Pharma Limited is an established player in the pharmaceutical manufacturing sector, specializing in niche dosage forms. The company has a significant international presence, serving over 60 countries. It is privately held, operating in Manufacturing, and is based in Mumbai.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.